Glutathione-related factors are not correlated with sensitivity of human tumour cells to actinomycin D

被引:2
作者
Zhang, K
Yang, EB
Zhao, YN
Wong, KP
Mack, P
机构
[1] Singapore Gen Hosp, Dept Expt Surg, Singapore 169608, Singapore
[2] Natl Univ Singapore, Dept Biochem, Singapore 119260, Singapore
基金
英国医学研究理事会;
关键词
glutathione; glutathione S-transferase; glutathione reductase; glutathione peroxidase; glutathione conjugate export pump; melphalan; actinomycin D; human tumour cells;
D O I
10.1016/S0304-3835(99)00364-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Glutathione (GSH) contents and activities of glutathione S-transferases (GST), glutathione reductase (GSH-RD), glutathione peroxidase (GSHpx) and glutathione conjugate export pump (GS-X pump) were determined in eight human tumour cell lines with different sensitivities to melphalan, a substrate of glutathione conjugation, and actinomycin D which has not been shown to be detoxified by glutathione-related mechanisms. Chang liver cells with highest GSH content and highest activities of GST, GSH-RD, GSHpx and GS-X pump were found to be most resistant to melphalan. Statistical analysis showed significant correlations between sensitivities of the human tumour cells to melphalan and the glutathione-related factors (r = 0.72-0.79; except for GST, r = 0.65, P = 0.08), while there were no significant correlations observed between sensitivities of the human tumour cells to actinomycin D and all the glutathione-related factors tested (r = -0.25-0.14). Significant correlations of the glutathione-related factors to resistance of human tumour cells to melphalan, a substrate of glutathione conjugation, but not to resistance of the human tumour cells to actinomycin D which has not been shown to be detoxified by glutathione-related mechanisms suggested that glutathione-related mechanisms contribute to drug resistance by increased detoxification of the drugs involved. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:213 / 220
页数:8
相关论文
共 29 条
[1]   Buthionine sulphoximine alone and in combination with melphalan (L-PAM) is highly cytotoxic for human neuroblastoma cell lines [J].
Anderson, CP ;
Tsai, J ;
Chan, W ;
Park, CK ;
Tian, L ;
Lui, RM ;
Forman, HJ ;
Reynolds, CP .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (12) :2016-2019
[2]   Multidrug resistance protein-mediated transport of chlorambucil and melphalan conjugated to glutathione [J].
Barnouin, K ;
Leier, I ;
Jedlitschky, G ;
Pourtier-Manzanedo, A ;
König, J ;
Lehmann, WD ;
Keppler, D .
BRITISH JOURNAL OF CANCER, 1998, 77 (02) :201-209
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   Rapid development of glutathione-S-transferase-dependent drug resistance in vitro and its prevention by ethacrynic acid [J].
Caffrey, PB ;
Zhu, M ;
Zhang, YX ;
Chinen, N ;
Frenkel, GD .
CANCER LETTERS, 1999, 136 (01) :47-52
[5]  
Chabncr BA, 1996, PHARMACOL BASIS THER, P1233
[6]   Sensitization effect of L-2-oxothiazolidine-4-carboxylate on tumor cells to melphalan and the role of 5-oxo-L-prolinase in glutathione modulation in tumor cells [J].
Chen, X ;
Batist, G .
BIOCHEMICAL PHARMACOLOGY, 1998, 56 (06) :743-749
[7]  
COMMANDEUR JNM, 1995, PHARMACOL REV, V47, P271
[8]  
DULIK DM, 1986, BIOCHEM PHARMACOL, V35, P3404
[9]   GLUTATHIONE-CONJUGATE TRANSPORT BY HUMAN COLON ADENOCARCINOMA CELLS (CACO-2 CELLS) [J].
ELFERINK, RPJO ;
BAKKER, CTM ;
JANSEN, PLM .
BIOCHEMICAL JOURNAL, 1993, 290 :759-764
[10]   Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity [J].
Ferrari, S ;
Mercuri, M ;
Rosito, P ;
Mancini, A ;
Barbieri, E ;
Longhi, A ;
Rimondini, S ;
Cesari, M ;
Ruggieri, P ;
Di Liddo, M ;
Bacci, G .
JOURNAL OF CHEMOTHERAPY, 1998, 10 (06) :484-491